/PRNewswire/ The Board of Directors of Karo Pharma Aktiebolag ("Karo Pharma" or the "Company") has resolved to apply for de-listing of the Company s shares.
/PRNewswire/ Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma" or the.
STOCKHOLM, Sept. 26, 2022 /PRNewswire/ Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma" or the "Company")
HUDDINGE, Sweden, July 21, 2022 /PRNewswire/ January - June Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the period.
HUDDINGE, Sweden, April 19, 2022 /PRNewswire/ Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa